ICU Medical Inc (ICUI) stock
ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3087% above fair value
$178.48+1.57 (+0.89%)
Close on Nov 18, 2026Market cap $4.46BP/E 148.7Yield –
ICU Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
ICU Medical's revenue for the twelve months ending Jun 30, 2026 was $2.16B, down 9.0% year over year. For fiscal 2025 it was $2.23B, down 6.3% from the year before. Over ten years it grew 20.6% a year on average. The highest annual figure on record is $2.38B in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.23B | -6.3% |
| FY2024 | Dec 31, 2024 | $2.38B | +5.4% |
| FY2023 | Dec 31, 2023 | $2.26B | -0.9% |
| FY2022 | Dec 31, 2022 | $2.28B | +73.2% |
| FY2021 | Dec 31, 2021 | $1.32B | +3.6% |
| FY2020 | Dec 31, 2020 | $1.27B | +0.4% |
| FY2019 | Dec 31, 2019 | $1.27B | -9.6% |
| FY2018 | Dec 31, 2018 | $1.40B | +8.3% |
| FY2017 | Dec 31, 2017 | $1.29B | +240.7% |
| FY2016 | Dec 31, 2016 | $379.37M | +11.0% |
| FY2015 | Dec 31, 2015 | $341.67M | +10.5% |
| FY2014 | Dec 31, 2014 | $309.26M | -1.4% |
| FY2013 | Dec 31, 2013 | $313.72M | -1.0% |
| FY2012 | Dec 31, 2012 | $316.87M | +4.9% |
| FY2011 | Dec 31, 2011 | $302.20M | +6.8% |
| FY2010 | Dec 31, 2010 | $282.96M | +23.6% |
| FY2009 | Dec 31, 2009 | $228.97M | +11.8% |
| FY2008 | Dec 31, 2008 | $204.73M | +8.8% |
| FY2007 | Dec 31, 2007 | $188.14M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $551.68M | +0.5% |
| Q1 FY2026 | Mar 31, 2026 | $530.23M | -12.3% |
| Q4 FY2025 | Dec 31, 2025 | $540.70M | -14.1% |
| Q3 FY2025 | Sep 30, 2025 | $536.99M | -8.9% |
| Q2 FY2025 | Jun 30, 2025 | $548.87M | -8.0% |
| Q1 FY2025 | Mar 31, 2025 | $604.70M | +6.7% |
| Q4 FY2024 | Dec 31, 2024 | $629.81M | +7.1% |
| Q3 FY2024 | Sep 30, 2024 | $589.13M | +6.5% |
| Q2 FY2024 | Jun 30, 2024 | $596.46M | +8.6% |
| Q1 FY2024 | Mar 31, 2024 | $566.66M | -0.4% |
| Q4 FY2023 | Dec 31, 2023 | $587.86M | +1.7% |
| Q3 FY2023 | Sep 30, 2023 | $553.31M | -7.5% |
| Q2 FY2023 | Jun 30, 2023 | $549.31M | -2.1% |
| Q1 FY2023 | Mar 31, 2023 | $568.65M | +4.7% |
| Q4 FY2022 | Dec 31, 2022 | $578.01M | +69.7% |
| Q3 FY2022 | Sep 30, 2022 | $597.86M | +77.9% |
| Q2 FY2022 | Jun 30, 2022 | $561.00M | +74.4% |
| Q1 FY2022 | Mar 31, 2022 | $543.12M | +70.8% |
| Q4 FY2021 | Dec 31, 2021 | $340.53M | +6.3% |
| Q3 FY2021 | Sep 30, 2021 | $336.06M | +5.5% |
| Q2 FY2021 | Jun 30, 2021 | $321.68M | +6.0% |
| Q1 FY2021 | Mar 31, 2021 | $318.05M | -3.2% |
| Q4 FY2020 | Dec 31, 2020 | $320.45M | +1.6% |
| Q3 FY2020 | Sep 30, 2020 | $318.57M | +3.6% |
| Q2 FY2020 | Jun 30, 2020 | $303.38M | -2.9% |
| Q1 FY2020 | Mar 31, 2020 | $328.61M | -0.7% |
| Q4 FY2019 | Dec 31, 2019 | $315.52M | -7.3% |
| Q3 FY2019 | Sep 30, 2019 | $307.47M | -6.0% |
| Q2 FY2019 | Jun 30, 2019 | $312.28M | -13.4% |
| Q1 FY2019 | Mar 31, 2019 | $330.93M | -11.0% |
| Q4 FY2018 | Dec 31, 2018 | $340.38M | -8.0% |
| Q3 FY2018 | Sep 30, 2018 | $327.17M | -4.7% |
| Q2 FY2018 | Jun 30, 2018 | $360.46M | +8.7% |
| Q1 FY2018 | Mar 31, 2018 | $372.03M | +50.2% |
| Q4 FY2017 | Dec 31, 2017 | $370.12M | +286.8% |
| Q3 FY2017 | Sep 30, 2017 | $343.24M | +253.5% |
| Q2 FY2017 | Jun 30, 2017 | $331.51M | – |
| Q1 FY2017 | Mar 31, 2017 | $247.74M | – |
| Q4 FY2016 | Dec 31, 2016 | $95.69M | – |
| Q3 FY2016 | Sep 30, 2016 | $97.11M | – |
See a number that looks wrong?